Nyrada Investor Briefing – 24 June
Nyrada Inc. (ASX: NYR) Webcast Replay
Nyrada Inc. (ASX: NYR) is a preclinical stage, drug discovery and development company, specialising in novel small molecule drugs to treat cardiovascular, neurological, and inflammatory diseases..
As a part of our ‘Meet the CEOs’ series, CEO James Bonnar provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 24th June 2020 at 12pm (AEST).